Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-28

Clinical Trial Update: Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal Colic [Phase 4]

View source ↗

Summary

Phase 4 trial comparing parecoxib 40 mg with ketoprofen 100 mg for efficacy and safety in acute renal colic; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketoprofen (Ketoprofen)
  • Parecoxib (parecoxib)

Snippet

Sponsor: Pfizer | Conditions: Pain | Phase 4 | Status: COMPLETED | Results posted: 2013-01-28